Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 26.31
-0.11 (-0.42%)
May 1, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 3.68 billion as of May 1, 2026. Its market cap has decreased by -13.57% in one year.
Market Cap
3.68B
Enterprise Value
4.60B
Revenue
3.01B
Ranking
n/a
PE Ratio
18.89
Stock Price
26.31
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 3.68B, a decrease of -26.34%. That is a compound annual growth rate of -0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.68B | -26.24% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 59.58B |
| Sigma Healthcare | 32.09B |
| Pro Medicus | 14.04B |
| Sonic Healthcare | 9.77B |
| Ramsay Health Care | 8.96B |
| Cochlear | 6.46B |
| Telix Pharmaceuticals | 5.28B |
| Mesoblast | 2.75B |